Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Community Health Worker Care Transitions Study

Not Applicable

Completed

Conditions: Hospitalism

Interventions: Behavioral: Community Health Worker

First Posted Date: 2017-03-21

Last Posted Date: 2020-02-24

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 600

Registration Number: NCT03085264

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Design and Validation of a New Assessment Tool for Lichen Planopilaris

Conditions: Lichen Planopilaris of Scalp
Lichen Planopilaris
Frontal Fibrosing Alopecia
Lichen Plano-Pilaris

Interventions: Diagnostic Test: Boston Grade of Activity in Lichen Planopilaris

First Posted Date: 2017-03-17

Last Posted Date: 2022-01-26

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 40

Registration Number: NCT03082560

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Assessing Efficacy of Intravenous Acetaminophen for Perioperative Pain Control for Oocyte Retrieval

Phase 4

Completed

Conditions: Pain, Postoperative
Infertility, Female

Interventions: Drug: IV Acetaminophen
Drug: PO Acetaminophen
Other: Placebo IV Acetaminophen
Other: Placebo PO Acetaminophen

First Posted Date: 2017-03-08

Last Posted Date: 2022-05-26

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 161

Registration Number: NCT03073980

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Vistusertib (AZD2014) For Recurrent Grade II-III Meningiomas

Phase 2

Active, not recruiting

Conditions: Meningioma

Interventions: Drug: AZD2014

First Posted Date: 2017-03-07

Last Posted Date: 2022-10-18

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 28

Registration Number: NCT03071874

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
Massachusetts general Hospital, Boston, Massachusetts, United States
🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States

Resilience Intervention for Older, HIV-Infected Women

Not Applicable

Completed

Conditions: Resilience, Psychological

Interventions: Behavioral: Relaxation Response Resiliency Program (3RP)

First Posted Date: 2017-03-07

Last Posted Date: 2019-10-28

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 13

Registration Number: NCT03071887

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Boston Medical Center, Boston, Massachusetts, United States

Support for Perinatal Adherence and Depression

Not Applicable

Completed

Conditions: Depression
Human Immunodeficiency Virus

Interventions: Behavioral: Integrating Nuanced Support for Perinatal adherence and Depression

First Posted Date: 2017-03-03

Last Posted Date: 2021-12-14

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 23

Registration Number: NCT03069417

Locations: 🇿🇦
MatCH Research, Durban, South Africa
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Identification/Characterization of Changes in Microscopic Colitis

Conditions: Colitis, Microscopic

First Posted Date: 2017-02-24

Last Posted Date: 2021-09-01

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 330

Registration Number: NCT03063957

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

A Pilot Study of Cognitive-Behavioral Therapy for Rumination Disorder (CBT-RD)

Not Applicable

Completed

Conditions: Rumination Disorder

Interventions: Behavioral: CBT-RD

First Posted Date: 2017-02-23

Last Posted Date: 2019-06-17

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 10

Registration Number: NCT03062696

Locations: 🇺🇸
Drexel University, Philadelphia, Pennsylvania, United States
🇺🇸
Ani Keshishian, Boston, Massachusetts, United States

Light Therapy as Treatment for Fatigue in Multiple Sclerosis

Not Applicable

Completed

Conditions: Multiple Sclerosis, Relapsing-Remitting

Interventions: Device: Light Therapy box

First Posted Date: 2017-02-23

Last Posted Date: 2020-05-13

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 35

Registration Number: NCT03060759

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

A Pilot Study Of Ga-68-DOTA-TOC Imaging In Participants With Small Bowel Carcinoid Tumors

Phase 1

Withdrawn

Conditions: Small Bowel Carcinoid Tumor

Interventions: Drug: Ga-68-DOTA-TOC
Device: Siemens PET/MR scanner
Other: Standard Siemens Software
Drug: LAR Octreotide

First Posted Date: 2017-02-20

Last Posted Date: 2019-06-21

Lead Sponsor: Massachusetts General Hospital

Registration Number: NCT03057509

Locations: 🇺🇸
Massachusetts general Hospital, Boston, Massachusetts, United States
🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy